Although Mallela et al. [19] concluded that NPRA signaling was involved in tumor growth through regulating angiogenesis, they only demonstrated that the numbers of CD31+ cells were decreased in the lung cancer sections of NPRA-KO mice compared with the wild-type mice by IHC staining. The gene discussed is PECAM1; the disease is lung cancer.